Incyte (INCY) Debt to Equity (2012 - 2026)

Incyte (INCY) reported Debt to Equity of $0.01 for Q1 2026, down 38.42% on a YoY basis from $0.01 in Q1 2025, and down 12.03% quarter-over-quarter from $0.01 in Q4 2025.

Incyte (INCY) Debt to Equity (2012 - 2026) Analysis & Trends

Incyte has reported Debt to Equity for 14 years, with the latest figure at $0.01 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity fell 38.42% year-over-year to $0.01; the trailing twelve-month figure through Mar 2026 stood at $0.01 (down 38.42% YoY), and the FY2025 full-year result was $0.01, down 30.04% from the prior year.
  • Debt to Equity for Q1 2026 stood at $0.01, down from $0.01 in the prior quarter.
  • The five-year high for Debt to Equity was $0.01 in Q3 2024, with the low at $0.01 in Q1 2024.
  • Historically, Debt to Equity has averaged $0.01 across 5 years, with a median of $0.01 in 2022.
  • Annual changes were most pronounced in 2024 — Debt to Equity surged 70.37% — and 2026, when it sank 38.42%.
  • Incyte's Debt to Equity stood at $0.01 in 2022, then declined by 11.45% to $0.01 in 2023, then soared by 53.73% to $0.01 in 2024, then plunged by 30.04% to $0.01 in 2025, then slipped by 12.03% to $0.01 in 2026.
  • The last three Debt to Equity figures came in at $0.01 (Q1 2026), $0.01 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.01
Jun 30, 2021 0.01